Cost-effectiveness analysis review of exemestane in the treatment of primary and advanced breast cancer

INTRODUCTION: Exemestane was approved in 2005 for adjuvant treatment of breast cancer. In this study, we aimed to assess whether it is cost-effective in comparison to available alternatives. MATERIAL AND METHODS: To evaluate the efficacy of exemestane, a systematic review was conducted by searching...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Hashemi-Meshkini, Amir, Keshavarz, Khosro, Gharibnaseri, Zahra, Kheirandish, Mehrnaz, Kebriaeezadeh, Abbas, Nikfar, Shekoufeh, Abdollahi, Mohammad
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Termedia Publishing House 2013
Θέματα:
Clinical Research
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3701982/
https://ncbi.nlm.nih.gov/pubmed/23847669
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2013.35347
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια